sun pharma

"Improvement in inflation probably is indicating clearly that the need for hawkish monetary policy may not be there for very long. And that did cheer up the market again, both in US as…
Read More...

Brokerage firm JPMorgan maintained an underweight rating on TCS, Morgan Stanley has an overweight rating on Sun Pharma and Morgan Stanley has downgraded HPCL to underweight but prefers…
Read More...

Mumbai: Shares of pharmaceutical companies remained in favour, rising for the eight day in a row Wednesday amid heavy volumes, as a spike in India's Covid cases and the prevailing…
Read More...

"The broader valuation comfort is there in banking and financial services particularly I think PSU banks is where there is a higher degree of valuation comfort and the quarterly preview…
Read More...

"In European markets yesterday again we reached some near all-time highs, some near 52-week highs, and we are still down so it sort of defies logic. And I think it is an opportunity for…
Read More...

on Thursday said it has entered into a definitive agreement to acquire US-based late stage biotech firm Concert Pharmaceuticals for $576 million.With this deal, India's largest drug…
Read More...

"The raw material cost had gone up more than the price increase therefore their margins are slightly muted in FY23 but FY24 should help see reduction in raw material cost and therefore…
Read More...

Indian shares lacked direction on Wednesday in the lead up to the key US inflation data on Thursday with both bulls and bears failing to make a headway. Equity indices closed flat in a…
Read More...

After opening in the negative territory on Tuesday, Indian equity indices bounced back amid volatile trading and closed higher on the second straight day, led by banking, financial and…
Read More...

The Nifty declined 2.5% last week in its steepest weekly fall since June 2022. According to technical analysts, the index, which closed at 17,806, has crucial support at 17,650-17,800,…
Read More...